TEVA PHARMACEUTICAL INDUSTRIES LIMITED Depreciation
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Depreciation of $421.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED depreciation for fiscal 2025 was $421.00M, a 10.62% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED depreciation for fiscal 2024 was $471.00M, a 12.29% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED depreciation for fiscal 2023 was $537.00M, a 6.77% decline from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED depreciation for fiscal 2022 was $576.00M, a 9.09% increase from fiscal 2021.
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $421.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $471.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | $537.00M 10-K · filed 2026-02-03 |
| 2022-12-31 | $576.00M 10-K · filed 2025-02-05 |
| 2021-12-31 | $528.00M 10-K · filed 2024-02-12 |
| 2020-12-31 | $537.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | $609.00M 10-K · filed 2022-02-09 |
| 2018-12-31 | $676.00M 10-K · filed 2021-02-10 |
| 2017-12-31 | $632.00M 10-K · filed 2020-02-21 |
| 2016-12-31 | $501.00M 10-K · filed 2019-02-19 |
| 2015-12-31 | $449.00M 10-K · filed 2018-02-12 |
| 2014-12-31 | $464.00M 20-F · filed 2017-02-15 |
| 2013-12-31 | $458.00M 20-F · filed 2016-02-11 |
| 2012-12-31 | $428.00M 20-F · filed 2015-02-09 |
| 2011-12-31 | $358.00M 20-F · filed 2014-02-10 |
| 2010-12-31 | $448.00M 20-F · filed 2013-02-12 |
| 2009-12-31 | $426.00M 20-F · filed 2012-02-17 |
| 2008-12-31 | $308.00M 20-F · filed 2011-02-15 |